Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.
Imamura Y, Kiyota N, Tahara M, Kodaira T, Hayashi R, Nishino H, Asada Y, Mitani H, Iwae S, Nishio N, Onozawa Y, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Kitabayashi R, Sasaki K, Homma A; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG‐HNCSG). Imamura Y, et al. Among authors: nishino h. Cancer Med. 2024 Sep;13(18):e70235. doi: 10.1002/cam4.70235. Cancer Med. 2024. PMID: 39348265 Free PMC article. Clinical Trial.
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.
Imamura Y, Kiyota N, Tahara M, Kodaira T, Hayashi R, Nishino H, Asada Y, Mitani H, Iwae S, Nishio N, Onozawa Y, Hanai N, Ohkoshi A, Hara H, Monden N, Nagaoka M, Minami S, Kitabayashi R, Sasaki K, Homma A; Head, Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Imamura Y, et al. Among authors: nishino h. Oral Oncol. 2024 Jul;154:106868. doi: 10.1016/j.oraloncology.2024.106868. Epub 2024 May 30. Oral Oncol. 2024. PMID: 38820889 Clinical Trial.
Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation.
Endo M, Fukuda Y, Okada K, Ogawa K, Nakamura M, Takahashi S, Murakami E, Shibayama C, Kawahara M, Akahane K, Onaga R, Nagatomo T, Kanazawa T, Nishino H, Mori H, Shirai K. Endo M, et al. Among authors: nishino h. In Vivo. 2023 Sep-Oct;37(5):2320-2326. doi: 10.21873/invivo.13335. In Vivo. 2023. PMID: 37652523 Free PMC article.
The association between initiation weekday of radiotherapy and local control in stage 1 glottic carcinoma: a retrospective analysis.
Endo M, Takahashi S, Fukuda Y, Okada K, Ogawa K, Nakamura M, Kawahara M, Akahane K, Murakami E, Shibayama C, Onaga R, Nagatomo T, Kanazawa T, Nishino H, Mori H, Shirai K. Endo M, et al. Among authors: nishino h. J Radiat Res. 2024 Dec 3;65(6):798-804. doi: 10.1093/jrr/rrae074. J Radiat Res. 2024. PMID: 39287117 Free PMC article.
Successful Preoperative QUAD SHOT for Bulky Parotid Carcinoma: Potential Preoperative Ultra-Hypofractionated Radiotherapy for Conversion Surgery.
Takahashi S, Endo M, Nagatomo T, Onaga R, Yamaguchi H, Yamamoto R, Fukuda Y, Ogawa K, Nakamura M, Okada K, Akahane K, Kawahara M, Nishino H, Kanazawa T, Mori H, Shirai K. Takahashi S, et al. Among authors: nishino h. Case Rep Oncol. 2023 Apr 14;16(1):218-226. doi: 10.1159/000529829. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37069898 Free PMC article.
1,272 results